The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of UGT1A1 gene polymorphism on survival in metastatic colorectal cancer patients treated with irinotecan-containing therapy.
 
Hiromichi Shirasu
No Relationships to Disclose
 
Kentaro Yamazaki
Honoraria - Bayer; Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Lilly; Merck Serono; Taiho Pharmaceutical; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Bristol-Myers Squibb Japan (Inst); Sanofi (Inst)
 
Mitsuhiro Furuta
No Relationships to Disclose
 
Masahiro Kawahira
No Relationships to Disclose
 
Takeshi Kawakami
No Relationships to Disclose
 
Yukio Yoshida
No Relationships to Disclose
 
Sadayuki Kawai
No Relationships to Disclose
 
Satoshi Hamauchi
No Relationships to Disclose
 
Akiko Todaka
Consulting or Advisory Role - Daiichi Sankyo; Taiho Pharmaceutical; Yakult Honsha
 
Takahiro Tsushima
Honoraria - Chugai Pharma; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda
 
Nozomu Machida
Speakers' Bureau - Taiho Pharmaceutical
Research Funding - MSD
 
Tomoya Yokota
No Relationships to Disclose
 
Akira Fukutomi
Honoraria - Daiichi Sankyo; Lilly Japan; Taiho Pharmaceutical; Yakult Honsha
Consulting or Advisory Role - Yakult Honsha
Research Funding - NanoCarrier (Inst); Taiho Pharmaceutical (Inst); Teijin Pharma (Inst)
 
Yusuke Onozawa
Honoraria - Bayer
 
Hirofumi Yasui
No Relationships to Disclose